Effect of the polymorphism of the angiotensin-converting enzyme gene on the drug treatment in patients with chronic heart failure

Journal of Central South University (Medical Sciences)

Volumn 29, Issue 6, 2004, Pages 686-689

  Huang, Wen Yan ^a   Sun, Ming ^a   Zhou, Hong Yan ^a   Pei, Zhi Fang ^a   Yang, Tian Lun ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Angiotensirrconverting enzyme; Gene; Heart failure; Polymorphism

Indexed keywords

BENAZEPRIL; BENZAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; METOPROLOL;

ADOLESCENT; ADULT; AGED; ARTICLE; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HUMAN; HYPERTENSION; MALE; MIDDLE AGED; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TREATMENT OUTCOME;

ADOLESCENT; ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BENZAZEPINES; CORONARY DISEASE; FEMALE; GENE FREQUENCY; GENOTYPE; HEART FAILURE, CONGESTIVE; HUMANS; HYPERTENSION; MALE; METOPROLOL; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; RENIN-ANGIOTENSIN SYSTEM; TREATMENT OUTCOME;

EID: 33846440533     PISSN: 16727347     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Pinto YM, van Gilst WH, Kingma JH, et al. Deletion-type allele of the angiotensirrconverting enzyme gene is associated with progressive ventricular dilation after anterior myocardial infarction [J]. J Am Coll Cardiol, 1995, 25(6):1622-1626.
2. McNamara DM, Hblubkov R, Janosko K, et al. Pharmacogenetic interactions between β-blocker therapy and the angiotensin-converting enzyme deletion polymorphism in patients with chronic heart failure [J]. Circulation, 2001, 103(12):1644-1648. (Pubitemid 32246611)
3. Sahn DJ, De Marin A, Kisslo J, et al. The committee on standardization of echocardiograp hy: recommendations regarding quantitation in M-mode echocardiograp hy: results of a survey of echocar diographic measurements [J]. Circulation, 1978, 58(6):1073-1078.
4. Quinones MA, Pickering E, Alexander J K. Percentage of shortening of the echocardiographie left ventricular dimensions: its use in determining ejection fraction and stroke volume [J]. Chest 1978, 74(1):59-65. (Pubitemid 8388719)
5. Rigat B, Hubert C, Corvol P, et al. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1) [J]. Nuc Acids Res, 1992;20(6):1433.
6. Lindpaintner K, Pfeffer MA, Kreutz R, et al. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischaemic heart disease [J]. N Engl J Med, 1995, 332(11):706-711.
7. Rigat B, Hubert C, Alhenc-Gelas F, et al. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels [J]. J Clin Invest, 1990, 86(4):1343-1346. (Pubitemid 20370444)
8. Danser AHJ, Schalekamp MADH, Box WA, et al. Angiotensirr converrting enzyme in the human heart: effect of the deletion/insertion polymorphism [J]. Circulation, 1995, 92(6):1387-1388.
9. Huang WY, Xie CH, Zhou HY, et al. Association of the angiotensin- converting enzyme gene polymorphism with chronic heart failure in Chinese Han patients [J]. Eur J Heart Fail, 2004, 6(1):23-27.